Clinical trial
Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in…
NCT00252122 · Children's Hospital of Philadelphia, Other · Terminated
Key facts
| NCT number | NCT00252122 |
|---|---|
| Title | Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease |
| Official title | A Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease |
| Lead sponsor | Children's Hospital of Philadelphia, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Sickle Cell Disease |
| Intervention type | Drug |
| Interventions | Ketamine |
| Enrollment | 3 |
| Start date | Jun 1, 2004 |
| Primary completion | Nov 1, 2005 |
| Completion | Jan 1, 2007 |
| First posted | Nov 11, 2005 |
| Last update posted | Mar 13, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: